New Aspects of Inotropic Drugs

  • M. Goenen
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 1)


The number of patients admitted to the intensive care unit with acute or chronic heart failure are increasing not at least because operations are carried out in patients with acute myocardial infarction, severe angina pectoris, post-infarction complications, acute endocarditis, advanced cardiopathies or for non-cardiac surgery in cardiac patients.


Chronic Heart Failure Open Heart Surgery Inotropic Agent Cardiac Lesion Cardiac Preload 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Braunwald E, Colucci W (1985) Evaluating the efficacy of new inotropic agents. JACC 3: 1570–1574Google Scholar
  2. 2.
    Braunwald E, Kloner R (1982) The stunned myocardium. Prolonged, postischemic ventricular dysfunction. Circulation 66: 1146–1149PubMedCrossRefGoogle Scholar
  3. 3.
    Bristow MR, Ginsburg R, Minobe W, et al (1982) Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 307: 205–211PubMedCrossRefGoogle Scholar
  4. 4.
    Carmeliet E (1984) Myocardial ischemia: reversible and irreversible changes. Circulation 70: 149–151PubMedCrossRefGoogle Scholar
  5. 5.
    Godfraind T (1984) Drug-induced cardionecrosis. Arch Toxicol suppl 7: 1–15PubMedCrossRefGoogle Scholar
  6. 6.
    Goenen M, Pedemonte O, Baele Ph, Jaumin P, et Trémouroux J (1985) Effets hémodynamiques de l’Amrinone sur le bas débit cardiaque après chirurgie coeur ouvert. Réanimation, Soins Intensifs et Médecine d’Urgence 3: 151–156Google Scholar
  7. 7.
    Goenen M, Pedemonte O, Baele Ph, Col J (1985) Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 56: 33B - 38BPubMedCrossRefGoogle Scholar
  8. 8.
    Leier CV, Huss P, Lewis RP, Unverferth DV (1982) Drug-induced conditioning in congestive heart failure. Circulation 65: 1382–1387PubMedCrossRefGoogle Scholar
  9. 9.
    Liang CS, Sherman LG, Hoherty JV, et al (1984) Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of Dobutamine. Circulation 69: 113–119PubMedCrossRefGoogle Scholar
  10. 10.
    Mancini D, Le Jemtel Th, Sonnenblick E (1985) Intravenous use of Amrinone for the treatment of the failing heart. Am J Cardiol 56: 8B - 15BPubMedCrossRefGoogle Scholar
  11. 11.
    Rona G (1985) Catecholamine cardiotoxicity J Mol Cell Cardiol 17: 291–306CrossRefGoogle Scholar
  12. 12.
    Scholz H (1983) Pharmacological actions of various inotropic agents. Eur J Cardiol 4: 161–172Google Scholar
  13. 13.
    Taylor St H, Verma S, Hussain M, Reynolds G, Jackson N, Hafizullah M, Richmund A, Silke B (1985) Intravenous Amrinone in left ventricular failure complicated by acute myocardial infarction. Am J Cardiol 56: 29B - 32BPubMedCrossRefGoogle Scholar
  14. 14.
    Weber KT, Andrews V, Janicki JS (1981) Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol 48: 164–169PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • M. Goenen

There are no affiliations available

Personalised recommendations